NEWRON PHARMA N/ IT0004147952 /
2024-04-19 11:00:44 AM | Chg. +0.420 | Volume | Bid11:00:44 AM | Ask11:00:44 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.100CHF | +6.29% | 117,686 Turnover: 808,297.720 |
7.100Bid Size: 1,861 | 7.140Ask Size: 384 | 125.1 mill.CHF | - | - |
GlobeNewswire
10:55 AM
Technip Energies Selected by Viridor to perform FEED on the Runcorn Energy-from-Waste Carbon Capture...
GlobeNewswire
10:45 AM
Himax Joins Forces with E Ink to Revolutionize Smart Retail with Premier of WiseEye™ AI at 2024 Touc...
Newsfile Corp
10:21 AM
Digital Doc Fosters Unprecedented Revenue Growth Through Its AI-Backed Practice Growth Platform
GlobeNewswire
10:07 AM
Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer
GlobeNewswire
10:00 AM
INVZ INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Innoviz Technologies Ltd. Inve...
GlobeNewswire
10:00 AM
FOXF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fox Factory Holding Corp. Inve...